Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIdox Group Regulatory News (IDOX)

  • There is currently no data for IDOX

AGM Trading update

28 Mar 2024 07:00

RNS Number : 5857I
IDOX PLC
28 March 2024
 

28 March 2024

Idox plc

('Idox' or the 'Group' or the 'Company')

AGM Trading update

Good momentum continues in the current financial year

Idox plc (AIM: IDOX), a leading supplier of specialist information management software and geospatial data solutions to the public and asset-intensive sectors, is pleased to issue a trading update for the period from 1 November 2023 to date, ahead of today's Annual General Meeting.

Highlights during the period include:

· Operational and financial performance continue to be in line with the Board's expectations and we remain confident about the outlook for the year.

· High levels of recurring revenue, contract renewals, orderbook and pipeline provide good visibility, leaving Idox well placed to grow by double digits in FY24.

· With a strong foundation in property and asset-based solutions and data services we continue to enhance and grow our capabilities across the Group.

· The integration of Emapsite (acquired August 2023) is progressing well and in line with our expectations.

· Idox has an attractive M&A pipeline with significant financial resources for larger, accretive and enhancing acquisitions at appropriate valuations.

A further trading update will be issued following the half year ending 30 April 2024.

David Meaden, Chief Executive Officer, said:

"We remain confident that Idox is well positioned for growth in FY24 and beyond. The Group has made a good start to the year and continues to trade in line with the Board's expectations. Our focus on securing high quality recurring revenue and repeatable services provides confidence in delivering double digit growth in FY24. We have a healthy balance sheet and are confident we can maximise the opportunities for profitable organic and inorganic growth whilst remaining resilient to the current macro-economic challenges."

For further information please contact:

Idox plc

+44 (0) 870 333 7101

Chris Stone, Non-Executive Chairman

investorrelations@idoxgroup.com

David Meaden, Chief Executive

 

Anoop Kang, Chief Financial Officer

 

 

Peel Hunt LLP (NOMAD and Broker)

+44 (0) 20 7418 8900

Paul Gillam

 

Adam Telling

 

 

MHP

+ 44 (0) 20 3128 8100

Reg Hoare

 idox@mhpgroup.com

Ollie Hoare

Matthew Taylor

 

About Idox plc

For more information see www.idoxplc.com @Idoxgroup

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBRGDXRDDDGSR
Date   Source Headline
7th Jan 20263:20 pmRNSForm 8.3 - IDOX PLC
7th Jan 20262:18 pmGNWForm 8.3 - Idox Plc
7th Jan 20262:10 pmGNWCorrection: Form 8.3 - Idox Plc
7th Jan 20262:08 pmGNWCorrection: Form 8.3 - Idox Plc
7th Jan 20262:06 pmGNWCorrection: Form 8.3 - Idox Plc
7th Jan 20262:04 pmGNWCorrection: Form 8.3 - Idox Plc
7th Jan 20262:01 pmGNWForm 8.3 - IDOX plc - Octopus Investments
7th Jan 20261:15 pmGNWPartial Withdrawal of Letter of Intent - IDOX plc - 07 01 2026 - (CGAML)
7th Jan 202612:59 pmGNWForm 8.3 - [IDOX PLC - 06 01 2026] - (CGWL)
7th Jan 202612:51 pmGNWForm 8.3 - [IDOX PLC - 06 01 2026] - (CGAML)
7th Jan 202612:00 pmRNSForm 8.5 (EPT/RI) Idox PLC
7th Jan 20267:00 amRNSUpdate on Letters of Intent
6th Jan 20263:15 pmRNSForm 8.3 - IDOX PLC
6th Jan 20262:01 pmGNWForm 8.3 - Idox Plc
6th Jan 20261:49 pmGNWForm 8.3 - IDOX plc - Octopus Investments
6th Jan 202612:00 pmRNSForm 8.5 (EPT/RI) Idox PLC
5th Jan 20263:56 pmRNSHolding(s) in Company
5th Jan 20263:17 pmRNSForm 8.3 - IDOX PLC
5th Jan 20263:15 pmRNSSwitch to Takeover Offer
5th Jan 20262:51 pmRNSForm 8.3 - IDOX PLC
5th Jan 20262:12 pmGNWForm 8.3 - IDOX plc - Octopus Investments
5th Jan 202612:48 pmGNWForm 8.3 - [IDOX PLC - 02 01 2026] - (CGWL)
5th Jan 202612:00 pmRNSForm 8.5 (EPT/RI) Idox PLC
2nd Jan 202612:26 pmGNWForm 8.3 - IDOX plc - Octopus Investments
2nd Jan 202612:00 pmRNSForm 8.5 (EPT/RI) Idox PLC
2nd Jan 20267:00 amRNSHolding(s) in Company
2nd Jan 20267:00 amRNSHolding(s) in Company
31st Dec 202512:42 pmBUSForm 8.3 - IDOX plc - Octopus Investments
31st Dec 202512:42 pmGNWForm 8.3 - IDOX plc - Octopus Investments
31st Dec 202510:00 amRNSUpdate on Letters of Intent
31st Dec 202510:00 amRNSUpdate on Letters of Intent
30th Dec 202512:32 pmGNWForm 8.3 - IDOX Plc - Octopus Investments
30th Dec 202512:00 pmRNSForm 8.5 (EPT/RI) Idox PLC
29th Dec 20253:00 pmGNWForm 8.3 - Idox Plc
29th Dec 20251:43 pmGNWForm 8.3 - IDOX plc - Octopus Investments
24th Dec 202512:36 pmGNWForm 8.3 - IDOX plc - Octopus Investments
24th Dec 202512:00 pmRNSForm 8.5 (EPT/RI) Idox PLC
24th Dec 202511:59 amGNWForm 8.3 - Idox Plc
24th Dec 202510:05 amRNSHolding(s) in Company
24th Dec 202510:05 amRNSHolding(s) in Company
24th Dec 20259:44 amGNWForm 8.3 - [IDOX PLC - 23 12 2025] - (CGWL)
24th Dec 20257:00 amRNSUpdate on Letters of Intent
23rd Dec 20252:48 pmGNWForm 8.3 - IDOX plc - Octopus Investments
23rd Dec 20251:56 pmGNWForm 8.3 - Idox Plc
23rd Dec 202512:00 pmRNSForm 8.5 (EPT/RI) Idox PLC
23rd Dec 20258:58 amGNWForm 8.3 - [IDOX PLC - 22 12 2025] - (CGWL)
22nd Dec 20253:17 pmRNSForm 8.3 - IDOX PLC
22nd Dec 20253:13 pmRNSForm 8.3 - IDOX PLC
22nd Dec 20253:00 pmBUSForm 8.3
22nd Dec 20252:42 pmGNWForm 8.3 - IDOX plc - Octopus Investments

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.